Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (CrossMab)
TypeName: Business Offer
Category:
Offer Date:2019/05/24
Country: United States
Summary: Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can bind two factors simultaneously. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.https://www.creative-biolabs.com/bsab/symbolsearch-ca125%2520%2526%2520her2.htm